Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Guardant Health Inc shares valued at $6,453 were sold by Tariq Musa on Sep 17 ’25. At $55.63 per share, Tariq Musa sold 116 shares. The insider’s holdings dropped to 7,591 shares worth approximately $0.48 million following the completion of this transaction.
Also, POTTER MYRTLE S sold 26 shares, netting a total of over 1,446 in proceeds. Following the sale of shares at $55.63 each, the insider now holds 18,281 shares.
Before that, POTTER MYRTLE S had added 26 shares to its account. In a trade valued at $1,446, the Director bought Guardant Health Inc shares for $55.62 each.
As published in a research note from Wolfe Research on September 25, 2025, Guardant Health Inc [GH] has been rated up from a Peer perform to an Outperform and the price target has been revised to $75. As of April 10, 2025, Mizuho has initiated its “an Outperform” rating for GH. Earlier on January 23, 2025, Barclays initiated its rating. Their recommendation was “an Overweight” for GH stock.
Analyzing GH Stock Performance
On last trading session, Guardant Health Inc [NASDAQ: GH] rose 0.27% to $62.65. The stock’s lowest price that day was $61.67, but it reached a high of $63.575 in the same session. During the last five days, there has been a surge of approximately 8.64%. Over the course of the year, Guardant Health Inc shares have jumped approximately 173.82%. Shares of the company reached a 52-week high of $68.00 on 09/02/25 and a 52-week low of $30.97 on 01/02/25.
Support And Resistance Levels for Guardant Health Inc (GH)
According to the 24-hour chart, there is a support level at 61.67, which, if violated, would cause prices to drop to 60.69. In the upper region, resistance lies at 63.63. The next price resistance is at 64.61. RSI (Relative Strength Index) is 62.00 on the 14-day chart, showing neutral technical sentiment.
Is Guardant Health Inc subject to short interest?
Stocks of Guardant Health Inc saw a sharp rise in short interest on 2025-09-15 jumping by 0.56 million shares to 8.74 million. Data from Yahoo Finance shows that the short interest on 2025-08-15 was 8.19 million shares. A jump of 6.37% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 3.67 of the overall float, the days-to-cover ratio (short ratio) jumped to 3.67.
Which companies own the most shares of Guardant Health Inc (GH)?
In terms of Guardant Health Inc share price expectations, FactSet research, analysts set an average price target of 75 in the next 12 months, up nearly 20.04% from the previous closing price of $62.48. Analysts anticipate Guardant Health Inc stock to reach 80 by 2025, with the lowest price target being 70. In spite of this, 13 analysts ranked Guardant Health Inc stock as Buy at the end of 2025. On June 28, 2024, Guggenheim assigned a price target of “a Buy” to the stock and upgraded coverage with a $36.
